• Information for Healthcare Professionals Home
• Drug Information
• Safety Information
• Clinical Trials, Research Tools
• Continuing Education

• FDA Acronyms and Abbreviations
• A - Z Index
• Contact Us

• March 5.Public Health Advisory: Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings. Information

• February 25. FDA takes new regulatory action against Ranbaxy’s Paonta Sahib plant in India. FDA News

• February 23 Information for Healthcare Professionals for Zonisamide. Information

• February 19. FDA issues Updated Safety Information about Raptiva (efalizumab). Information

• February 9. FDA to meet with drug companies about REMS for certain opioid drugs. Information

• February 4. FDA issues an Early Communication about an Ongoing Safety Review Xigris (Drotrecogin alfa [activated]) Drug Information

Previous News Items

• FDA Online Tutorial: An Introduction to the Improved FDA Prescription Drug Labeling
• Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book)
• HIV and AIDS - index to information on HIV/AIDS treatment and therapies
• New Requirements for Prescribing Information
• National Drug Code Directory - current list of all drugs manufactured, prepared, propagated, compounded, or processed for commercial distribution
• Drug Preparedness and Response to Bioterrorism

Search for Brand Name and Generic Drugs
current and archival drug labels, drug approval histories, and more

find a generic equivalent to a drug

report adverse events or product problems

sign up for FDA updates

find career opportunities at FDA